Quantitative analysis of the novel anticancer drug ABT-518, a matrix metalloproteinase inhibitor, plus the screening of six metabolites in human plasma using high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
E. Stokvis, H. Rosing, M. Crul, M. J. Rieser, A. J. R. Heck, J. H. M. Schellens, J. H. BeijnenVolume:
39
Year:
2004
Language:
english
Pages:
12
DOI:
10.1002/jms.579
File:
PDF, 245 KB
english, 2004